Western blot analysis of BK channel β 1‐subunit expression should be interpreted cautiously when using commercially available antibodies

Large conductance Ca 2+ ‐activated K + (BK) channels consist of pore‐forming α ‐ and accessory β ‐subunits. There are four β ‐subunit subtypes ( β 1– β 4), BK β 1‐subunit is specific for smooth muscle cells (SMC). Reduced BK β 1‐subunit expression is associated with SMC dysfunction in animal models of human disease, because downregulation of BK β 1‐subunit reduces channel activity and increases SMC contractility. Several anti‐BK β 1‐subunit antibodies are commercially available; however, the specificity of most antibodies has not been tested or confirmed in the tissues from BK β 1‐subunit knockout (KO) mice. In this study, we tested the specificity and sensitivity of six commercially available antibodies from five manufacturers. We performed western blot analysis on BK β 1‐subunit enriched tissues (mesenteric arteries and colons) and non‐SM tissue (cortex of kidney) from wild‐type (WT) and BK β 1‐KO mice. We found that antibodies either detected protein bands of the appropriate molecular weight in tissues from both WT and BK β 1‐KO mice or failed to detect protein bands at the appropriate molecular weight in tissues from WT mice, suggesting that these antibodies may lack specificity for the BK β 1‐subunit. The absence of BK β 1‐subunit mRNA expression in arteries, colons, and kidneys from BK β 1‐KO mice was confirmed by RT‐PCR analysis. We conclude that these commercially available antibodies might not be reliable tools for studying BK β 1‐subunit expression in murine tissues under the denaturing conditions that we have used. Data obtained using commercially available antibodies should be interpreted cautiously. Our studies underscore the importance of proper negative controls in western blot analyses.